Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Colman

Showing results (251-260 of 265) with videos related to

Pageof 27
Sort By:
Biochemistry|July 16, 1996
Involvement of arginine 143 in nucleotide substrate binding at the active site of adenylosuccinate synthetase from Escherichia coliO A Moe, J F Baker-Malcolm, W Wang, et al.
Transactions of the Association of American Physicians|January 1, 1980
Identification of two distinct adenosine diphosphate receptors in human plateletsR W Colman, W R Figures, R F Colman, et al.
Transactions of the Association of American Physicians|January 1, 1987
Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogenR N Puri, E J Gustafson, F X Zhou, et al.
Nature Genetics|September 23, 2008
Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycleDyonne T Hartong, Mayura Dange, Terri L McGee, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 24, 2009
The impact of executive functions on verb production in patients with Parkinson's diseaseKatrien S F Colman, Janneke Koerts, Marije van Beilen, et al.
Archives of Biochemistry and Biophysics|June 1, 1989
Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpainR N Puri, F X Zhou, H Bradford, et al.
Biochemistry|February 28, 2002
A nonhydrolyzable reactive cAMP analogue, (S(p))-8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic S-(methyl)monophosphorothioate, irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase at micromolar concentrationsSu H Hung, K S Madhusoodanan, Robert L Boyd, et al.
The Journal of Biological Chemistry|July 5, 1985
Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclaseD C Mills, W R Figures, L M Scearce, et al.
The Journal of Biological Chemistry|July 29, 2006
New insights from the structure-function analysis of the catalytic region of human platelet phosphodiesterase 3A: a role for the unique 44-amino acid insertSu-Hwi Hung, Wei Zhang, Robin A Pixley, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|April 1, 1992
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclaseD C Mills, R Puri, C J Hu, et al.
Pageof 27

Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
Biochemistry|July 16, 1996
Involvement of arginine 143 in nucleotide substrate binding at the active site of adenylosuccinate synthetase from Escherichia coliO A Moe, J F Baker-Malcolm, W Wang, et al.
Transactions of the Association of American Physicians|January 1, 1980
Identification of two distinct adenosine diphosphate receptors in human plateletsR W Colman, W R Figures, R F Colman, et al.
Transactions of the Association of American Physicians|January 1, 1987
Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogenR N Puri, E J Gustafson, F X Zhou, et al.
Nature Genetics|September 23, 2008
Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycleDyonne T Hartong, Mayura Dange, Terri L McGee, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 24, 2009
The impact of executive functions on verb production in patients with Parkinson's diseaseKatrien S F Colman, Janneke Koerts, Marije van Beilen, et al.
Archives of Biochemistry and Biophysics|June 1, 1989
Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpainR N Puri, F X Zhou, H Bradford, et al.
Biochemistry|February 28, 2002
A nonhydrolyzable reactive cAMP analogue, (S(p))-8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic S-(methyl)monophosphorothioate, irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase at micromolar concentrationsSu H Hung, K S Madhusoodanan, Robert L Boyd, et al.
The Journal of Biological Chemistry|July 5, 1985
Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclaseD C Mills, W R Figures, L M Scearce, et al.
The Journal of Biological Chemistry|July 29, 2006
New insights from the structure-function analysis of the catalytic region of human platelet phosphodiesterase 3A: a role for the unique 44-amino acid insertSu-Hwi Hung, Wei Zhang, Robin A Pixley, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|April 1, 1992
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclaseD C Mills, R Puri, C J Hu, et al.
Pageof 27